Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Oct;98(1):163-8.
doi: 10.1111/j.1365-2249.1994.tb06624.x.

Progressive increase of CD7- T cells in human blood lymphocytes with ageing

Affiliations

Progressive increase of CD7- T cells in human blood lymphocytes with ageing

S Kukel et al. Clin Exp Immunol. 1994 Oct.

Abstract

CD7 is one of the major surface antigens expressed very early during T cell ontogeny. Lack of CD7 expression on mature T cells is regarded as a classical feature of malignant T cells in certain forms of cutaneous T cell lymphoma. Previously, we identified a CD7- subset of peripheral blood T lymphocytes in normal human individuals. In this study we determined the portion of CD7- T cells in the peripheral blood of healthy volunteers ranging in age from 8 months to 90 years (n = 85) and in cord blood of full-term infants (n = 14). Furthermore, this CD7- subset was characterized in detail by the use of MoAbs and three-colour flow cytometry. In cord blood no CD7- T cells could be detected. After birth, percentage and absolute number of CD7- T cells increased with age. Independently of age, most CD7-CD3+ cells belonged to the CD4+ subpopulation. Focusing on the latter we could demonstrate the predominance of the CD45RO+CD45RA- phenotype in the CD7- subset. Furthermore, CD7- T cells contained a higher number of cells expressing activation markers and the CD57 antigen, but a reduced number of CD62L+ cells in comparison with CD7+ T cells.

PubMed Disclaimer

References

    1. J Immunol. 1985 Sep;135(3):1752-9 - PubMed
    1. Blood. 1983 Oct;62(4):722-8 - PubMed
    1. J Immunol. 1988 Mar 1;140(5):1401-7 - PubMed
    1. J Immunol. 1988 Mar 1;140(5):1435-41 - PubMed
    1. J Immunol. 1988 Apr 1;140(7):2171-8 - PubMed